ZNF160 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.320800E-01
Normal-vs-Stage2
4.288800E-01
Normal-vs-Stage3
3.154000E-01
Normal-vs-Stage4
5.798800E-01
Stage1-vs-Stage2
9.915000E-01
Stage1-vs-Stage3
1.127440E-01
Stage1-vs-Stage4
1.340400E-01
Stage2-vs-Stage3
1.609590E-01
Stage2-vs-Stage4
2.148800E-01
Stage3-vs-Stage4
2.805800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.302000E-01
Normal-vs-AfricanAmerican
3.981600E-01
Normal-vs-Asian
4.053400E-01
Caucasian-vs-AfricanAmerican
6.428400E-01
Caucasian-vs-Asian
6.160000E-01
AfricanAmerican-vs-Asian
9.486000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.210000E-01
Normal-vs-Female
4.396000E-01
Male-vs-Female
5.345000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.650000E-01
Normal-vs-Age(41-60Yrs)
4.864400E-01
Normal-vs-Age(61-80Yrs)
4.105400E-01
Normal-vs-Age(81-100Yrs)
3.637800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.168400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.721200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.610800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.896300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.954000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.589200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.729600E-01
Normal-vs-Daily Drinker
4.154400E-01
Normal-vs-Weekly Drinker
4.099600E-01
Normal-vs-Occasional Drinker
5.126400E-01
Normal-vs-Social Drinker
4.344000E-01
Non Drinker-vs-Daily Drinker
3.994000E-01
Non Drinker-vs-Weekly Drinker
4.790600E-01
Non Drinker-vs-Occasional Drinker
1.732100E-02
Non Drinker-vs-Social Drinker
2.434200E-01
Daily Drinker-vs-Weekly Drinker
9.316600E-01
Daily Drinker-vs-Occasional Drinker
1.823160E-01
Daily Drinker-vs-Social Drinker
7.751000E-01
Weekly Drinker-vs-Occasional Drinker
1.682600E-01
Weekly Drinker-vs-Social Drinker
7.029200E-01
Occasional Drinker-vs-Social Drinker
2.992800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.275800E-02
Normal-vs-Grade 2
8.837200E-03
Normal-vs-Grade 3
1.625640E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.143400E-01
Grade 1-vs-Grade 3
8.376600E-01
Grade 1-vs-Grade 4
7.275800E-02
Grade 2-vs-Grade 3
8.772600E-01
Grade 2-vs-Grade 4
8.837200E-03
Grade 3-vs-Grade 4
1.625640E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.842800E-01
Normal-vs-NonDiabetic
4.422400E-01
Diabetic-vs-NonDiabetic
4.592100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.665800E-01
Normal-vs-NoPancreatitis
4.221800E-01
Pancreatitis-vs-NoPancreatitis
2.334400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.109800E-01
Normal-vs-N1
4.345200E-01
N0-vs-N1
4.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.236800E-01
Normal-vs-TP53-NonMutant
3.637600E-01
TP53-Mutant-vs-TP53-NonMutant
1.551240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
